| STUDY NUMBER
|
DISEASE SITE
|
TITLE / AUTHOR LINE
|
VERSION
|
LINK TO MANUSCRIPT
|
| NRG-RTOG 0244
|
Head & Neck
|
Jha N, Deshmukh S, Seikaly H, Jacobs JR, McEwan AJ, Ryu S, Clausen C, Chakravarti A, Harris JR, Sharma AK, Pochini C, Markoe AM, Kim H, Koyfman S, Le Q. Results of Quality of Life for Phase II NRG Oncology RTOG 0244 Study Using Submandibular Salivary Gland Transfer Procedure for Prevention of Radiation-Induced Xerostomia in Head and Neck Cancer Patients.
|
May 29, 2015
|
MANUSCRIPT
|
| NRG-RTOG 9704
|
GI
|
Heestand GM, Murphy JD, Moughan J, Regine W, Luo J, Hellendag MG, Kunz PL, Fisher GA, Cuha C, Kozak M, Mowat R, Gaur R, Buyyounouski M, Chen Y, Chang DT, Koong AC. A Novel Biomarker Panel Examining Response to Adjuvant Pancreatic Cancer Therapy in NRG Oncology RTOG 9704.
|
September 22, 2015
|
MANUSCRIPT
|
| NRG-RTOG 0229
|
Lung
|
Krasna MJ, Paulus R, Suntharalingam M, Edelman MJ, Decker RH, McCabe V, Garces YI, Dobelbower MC, Elizabeth E, Huang TW, Choy H. Surgical Resection Following Neoadjuvant Concurrent Chemotherapy and High Dose Radiotherapy for Stage III NSCLC: Results of NRG Oncology RTOG 0229.
|
June 21, 2017
|
MANUSCRIPT
|
| NRG-RTOG Clinical Trials Recruitment
|
Multi
|
Hanisch LJ, Rearden J, James J, Thomas T, Gaffney D, NEading J, Neimanis D, Stern J, Consoli SJ, Pugh SL, Bruner DW. Identification of Patient-Level Barriers and Facilitators to NRG Oncology/RTOG Clinical Trials Recruitment
|
November 14, 2017
|
MANUSCRIPT
|
| NRG-RTOG 0212 and 0214
|
Lung
|
Gondi V, Paulus R, Bruner DW, Gore EM, Wolfson AH, Werner-Wasik M, Sun AY, Videtic GMM, Suntharalingam M, Jeter MD, Yeh AM, Bove JA, Robinson CG, Ahmed S, Gopaul DD, Gaspar LE, Dominello MM, Choy H, Movsas B. Prognostic Significance of Decline in Patient-Reported Quality of Life during Early Lung Cancer Survivorship: Pooled Secondary Analysis of RTOG 0212 and 0214.
|
November 24, 2020
|
MANUSCRIPT
|
| NSABP B-24
|
Breast
|
Julian T, Vicini F, Costantino JP, Duggal S, Wickerham L, Arthur DW, Land SR, Wapnir IL, Dignam JJ, Mamounas EP, White JR, Womark N. Is Boost Therapy Necessary in the Treatment of DCIS with Breast-Conserving Therapy?
|
N/A
|
MANUSCRIPT
|
| NRG-RTOG 0418
|
Gynecologic
|
Jhingran A, Witner K, Portelance L, Miller BE, Salehpour MR, Gaur R, Souhami L, Small W, Gaffney D. Efficacy and Safety of IMRT After Surgery in Patients with Endometrial Cancer: RTOG 0418 Phase II Study
|
N/A
|
MANUSCRIPT
|
| NRG-RTOG 0418
|
Gynecologic
|
Portelance L, Moughan J, Jhingran A, Miller BE, Salehpour MR, D'Souza D, Haddock MG, Rotman M, Souhami L, Smith M, Eisbruch A, Poppe M, Gaffney DK. Phase II Study on the Feasibility of Intensity Modulated Radiation Therapy (IMRT) in a Mulit-Institutional Setting for Post Operative Concomitant Chemoradiation for Patients with Cervical Cancer. NRG Oncology/RTOG 0418. Primary and Secondary Endpoint Results.
|
N/A
|
MANUSCRIPT
|
| NRG-RTOG 9410
|
Lung
|
Langer CJ, Hu C, Curran WJ, Komaki RR, Lee JS, Cox JD, McGarry RC, Padula GDA, Faria SL, Smith CJ, Michalski JM, Wener-Wasik M, Sause WT, Kim HE, Millenson MM, Kunos CA, Paulus R, Bradley JD. Do Elderly Patients with Locally Advanced Non-Small Cell Lung Cancer Benefit from Combined Modality Therapy? A Secondary Analysis of RTOG 94-10
|
N/A
|
MANUSCRIPT
|
| NRG-RTOG 0241
|
Lung
|
Langer CJ, Paulus R, Werner-Wasik M, Lilenbaum R, Samuels M, Osmundsen E, Koprowski C, Johnson F, Spencer SA, Choy H. Radiation Therapy Oncology Group (RTOG) 0241: Phase I study of irinotecan and cisplatin in combination with twice daily thoracic radiotherapy (45Gy) or once daily thoracic radiotherapy (70Gy) in patients with limited stage small cell carcinoma of the lung (LD-SCLC).
|
N/A
|
MANUSCRIPT
|
| NRG-RTOG 0630
|
Sarcoma
|
Wilmoth M, Harris J, Wang D, Kirsch DG, Okuno SH, Eisenberg BL, Kane JM III, Li XA, Lucas D, Kraybill W, Freeman CR, Finkelstein SE, Hitchcock Y, Salerno KE, Bedi M, Godette KD, Peterson IA, Movsas B. Quality of Life Outcomes Associated with Primary Soft Tissue Sarcomas of the Extremity.
|
N/A
|
MANUSCRIPT
|